Local Institution - 129

Madison, Wisconsin 53792-2454

0 studies enrolling now · 1 studies all time

What they study most

Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Primary Myelofibrosis

Studies at this site

• A Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib — Stopped early